Chest physiotherapy is a critical component of respiratory care aimed at improving airway clearance, enhancing lung function, and preventing complications in patients with various pulmonary conditions. This therapeutic approach employs a combination of manual techniques, postural drainage, percussion, vibration, and breathing exercises to mobilize mucus and secretions from the airways, facilitating their removal. Chest physiotherapy is particularly beneficial for individuals with chronic respiratory diseases, such as cystic fibrosis, bronchiectasis, chronic obstructive pulmonary disease, and pneumonia, as well as patients recovering from surgery or prolonged mechanical ventilation. Implementation requires a thorough assessment of the patient’s lung status, airway obstruction patterns, and overall health to tailor interventions effectively. Collaboration between physiotherapists, pulmonologists, and nursing staff ensures safe and coordinated care, optimizing both efficacy and patient comfort. Education and active participation of patients or caregivers in performing techniques at home enhance long-term outcomes, including reduced frequency of infections, improved oxygenation, and increased exercise tolerance. Advances in technology, such as mechanical devices that simulate manual techniques, have expanded the accessibility and consistency of therapy. Evidence indicates that consistent application of chest physiotherapy not only aids in symptom relief but also contributes to better quality of life and reduced hospitalizations. By combining skilled techniques, patient engagement, and individualized care plans, chest physiotherapy supports airway health, promotes respiratory efficiency, and strengthens overall lung function in both acute and chronic respiratory conditions.
Title : Global warming and increasing respiratory illnesses
Yazdan Mirzanejad, University of British Columbia, Canada
Title :
Saurabh Chattopadhyay, University of Kentucky, United States
Title : Risk factors for mycobacterium avium complex infections in patients with chronic obstructive pulmonary disease
Alizaman Sadigov, Medical University, United States
Title : Managing integration and interoperability in transformed pulmonology, respiratory medicine and lung health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted lung cancer therapy and advancing personalized cancer care
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Advancements in pulmonology and respiratory care through the view of Personalized and Precision Medicine (PPM) and biodesign-driven translational applications
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation